These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
523 related articles for article (PubMed ID: 11445733)
21. Coagulation and sepsis. Levi M; van der Poll T Thromb Res; 2017 Jan; 149():38-44. PubMed ID: 27886531 [TBL] [Abstract][Full Text] [Related]
22. Absence of thrombin-activatable fibrinolysis inhibitor protects against sepsis-induced liver injury in mice. Renckens R; Roelofs JJ; ter Horst SA; van 't Veer C; Havik SR; Florquin S; Wagenaar GT; Meijers JC; van der Poll T J Immunol; 2005 Nov; 175(10):6764-71. PubMed ID: 16272333 [TBL] [Abstract][Full Text] [Related]
23. Liver-lung interactions in critical illness. Matuschak GM New Horiz; 1994 Nov; 2(4):488-504. PubMed ID: 7804798 [TBL] [Abstract][Full Text] [Related]
24. Neutrophils sequestered in the liver suppress the proinflammatory response of Kupffer cells to systemic bacterial infection. Holub M; Cheng CW; Mott S; Wintermeyer P; van Rooijen N; Gregory SH J Immunol; 2009 Sep; 183(5):3309-16. PubMed ID: 19641138 [TBL] [Abstract][Full Text] [Related]
25. The coagulant response in sepsis and inflammation. Levi M Hamostaseologie; 2010 Jan; 30(1):10-2, 14-6. PubMed ID: 20162247 [TBL] [Abstract][Full Text] [Related]
26. The Inflammatory and Hemostatic Response in Sepsis and Meningococcemia. Boeddha NP; Bycroft T; Nadel S; Hazelzet JA Crit Care Clin; 2020 Apr; 36(2):391-399. PubMed ID: 32172820 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of Kupffer cells reduced CXC chemokine production and liver injury. Mosher B; Dean R; Harkema J; Remick D; Palma J; Crockett E J Surg Res; 2001 Aug; 99(2):201-10. PubMed ID: 11469888 [TBL] [Abstract][Full Text] [Related]
28. Complementary adhesion molecules promote neutrophil-Kupffer cell interaction and the elimination of bacteria taken up by the liver. Gregory SH; Cousens LP; van Rooijen N; Döpp EA; Carlos TM; Wing EJ J Immunol; 2002 Jan; 168(1):308-15. PubMed ID: 11751975 [TBL] [Abstract][Full Text] [Related]
29. Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis. Dhainaut JF; Yan SB; Cariou A; Mira JP Crit Care Med; 2002 May; 30(5 Suppl):S318-24. PubMed ID: 12004254 [TBL] [Abstract][Full Text] [Related]
30. Clinical expert round table discussion (session 3) at the Margaux Conference on Critical Illness: the role of activated protein C in severe sepsis. Bernard G; Artigas A; Dellinger P; Esmon C; Faist E; Faust SN; Fischer CJ; Fumagalli R; grinnell BW; Sprung C Crit Care Med; 2001 Jul; 29(7 Suppl):S75-7. PubMed ID: 11445738 [No Abstract] [Full Text] [Related]
31. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. Sander LE; Sackett SD; Dierssen U; Beraza N; Linke RP; Müller M; Blander JM; Tacke F; Trautwein C J Exp Med; 2010 Jul; 207(7):1453-64. PubMed ID: 20530204 [TBL] [Abstract][Full Text] [Related]
32. Microvascular coagulopathy and disseminated intravascular coagulation. ten Cate H; Schoenmakers SH; Franco R; Timmerman JJ; Groot AP; Spek CA; Reitsma PH Crit Care Med; 2001 Jul; 29(7 Suppl):S95-7; discussion S97-8. PubMed ID: 11445741 [TBL] [Abstract][Full Text] [Related]
33. The importance of immune dysfunction in determining outcome in acute liver failure. Antoniades CG; Berry PA; Wendon JA; Vergani D J Hepatol; 2008 Nov; 49(5):845-61. PubMed ID: 18801592 [TBL] [Abstract][Full Text] [Related]
34. Hepatic (dys-)function during inflammation. Monshouwer M; Hoebe KH Toxicol In Vitro; 2003; 17(5-6):681-6. PubMed ID: 14599463 [TBL] [Abstract][Full Text] [Related]
35. Adenosine monophosphate-activated protein kinase activation protects against sepsis-induced organ injury and inflammation. Escobar DA; Botero-Quintero AM; Kautza BC; Luciano J; Loughran P; Darwiche S; Rosengart MR; Zuckerbraun BS; Gomez H J Surg Res; 2015 Mar; 194(1):262-72. PubMed ID: 25456115 [TBL] [Abstract][Full Text] [Related]
36. Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Levi M; de Jonge E; van der Poll T Crit Care Med; 2001 Jul; 29(7 Suppl):S90-4. PubMed ID: 11445740 [TBL] [Abstract][Full Text] [Related]
37. Advances in sepsis-associated liver dysfunction. Wang D; Yin Y; Yao Y Burns Trauma; 2014; 2(3):97-105. PubMed ID: 27602369 [TBL] [Abstract][Full Text] [Related]
38. Crosstalk between inflammation and thrombosis. Esmon CT Maturitas; 2004 Apr; 47(4):305-14. PubMed ID: 15063484 [TBL] [Abstract][Full Text] [Related]
39. Genetics of coagulation factors in acute lung injury. Russell JA Crit Care Med; 2003 Apr; 31(4 Suppl):S243-7. PubMed ID: 12682447 [TBL] [Abstract][Full Text] [Related]
40. Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants. Taylor FB Crit Care Med; 2001 Jul; 29(7 Suppl):S78-89. PubMed ID: 11445739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]